Related Experiment Video

Updated: Sep 30, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Lipid-lowering effects of fluvastatin in renal transplant patients. A clinical observation

S M Lal1, N Gupta, O Georgiev

  • 1Department of Internal Medicine, University of Missouri-Columbia Health Sciences Center, USA.

The International Journal of Artificial Organs
|January 1, 1997
PubMed

Insights

Fluvastatin therapy in renal transplant patients did not significantly lower cholesterol or triglycerides. However, it did significantly increase high-density lipoprotein cholesterol (HDL-C) without adverse effects.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Atherosclerosis-related cardiovascular disease is a major cause of death in renal transplant recipients.
  • Hypercholesterolemia is common in these patients, even with dietary interventions.

Purpose of the Study:

  • To assess the efficacy and safety of fluvastatin in hypercholesterolemic renal transplant patients.
  • To evaluate fluvastatin's impact on lipid profiles in this specific patient population.

Main Methods:

  • A study involving 12 renal transplant patients with persistent hypercholesterolemia.
  • Patients received fluvastatin (20 mg/day) for 8 weeks after a 6-week diet phase.
  • Lipid profiles (TC, LDL-C, TG, HDL-C) were compared to a control phase.

Main Results:

  • Fluvastatin therapy did not significantly reduce total cholesterol, LDL-C, or triglycerides.
  • A statistically significant increase in HDL-C was observed (p = 0.006).
  • No adverse biochemical effects were noted during the short-term treatment.

Conclusions:

  • Fluvastatin may improve HDL-C levels in renal transplant patients.
  • Further research is needed to confirm long-term efficacy and safety for cardiovascular risk reduction.

More Related Videos

Murine Kidney Transplant Technique08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...